compounding glp-1 fda Compounded GLP-1s are entering a new phase of scrutiny. With the targeting large-scale compounded manufacturing, patients are facing a moment where access, safety, and regulatory clarity all matter. In my semaglutide compounding news fda FDA

Note, no head-to-head studies of GLP-1RAs and SGLT-2 inhibitors or acarbose are available

Finally, 3,4-dihydroxybutyric acid may be a normal component of human urine, although increased levels have been observed in cases of succinic semialdehyde dehydrogenase deficiency, a disorder in which patients may also present with autistic features (91)

Jan 16, 2026 The Science of Copper Peptides and Hair Regrowth Your hair follicles are dying

The gut, often called the second brain, is home to trillions of microorganisms collectively known as the gut microbiome

Spironolactone warnings People with certain medical conditions must be monitored while taking spironolactone and may need treatment modifications